Profil
Sanjeev Ahuja worked as Chief Medical Officer at Celtaxsys, Inc. and Mayne Pharma Group Ltd.
He also worked as Chief Medical Officer at Fresh Tracks Therapeutics, Inc. from 2019 to 2020.
Ahuja holds an MBA from the University of Cincinnati and a doctorate from Armed Forces Medical College.
Ehemalige bekannte Positionen von Sanjeev Ahuja
| Unternehmen | Position | Ende |
|---|---|---|
| FRESH TRACKS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 29.02.2020 |
| MAYNE PHARMA GROUP LIMITED | Technik-/Wissenschafts-/F&E-Leiter | - |
Celtaxsys, Inc.
 Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Sanjeev Ahuja
| University of Cincinnati (Ohio) | Masters Business Admin |
| Armed Forces Medical College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| FRESH TRACKS THERAPEUTICS, INC. | Health Technology |
| MAYNE PHARMA GROUP LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Health Technology |
